Common documents for international medical device registration include corporate entity records, manufacturer authorization, product description, intended use, models and specifications, design and manufacturing information, risk management, performance verification or test reports, clinical evaluation or evidence, ISO
Answer: Common documents for international medical device registration generally include corporate entity documents, manufacturer authorization letters, product descriptions, intended use, models and specifications, design and manufacturing information, risk management, performance verification or test reports, clinical evaluation or clinical evidence, ISO 13485 or quality system documentation, labels and instructions for use, declarations of conformity, existing registration certificates, and post-market surveillance arrangements. The exact list varies by country, product category, risk class, and registration pathway. Companies should first perform classification assessment and a documentation gap assessment, then create a formal project-specific document list.
Published: 2026-07-08 09:00 | Updated: 2026-07-08 09:00
Assessment Logic
Companies should evaluate the target market, registration pathway, commercial launch plan, and current documentation status in the same table. If pathway assessment is not done first, subsequent rework is likely in local agent arrangements, labeling, testing, clinical evidence, or certificate maintenance.
Documentation Focus
Documentation preparation should focus on consistency across product description, intended use, models and specifications, risk management, performance verification, clinical or evaluation evidence, labels and instructions for use, quality system evidence, authorization documents, and post-market maintenance arrangements.
Common Misconceptions
A common misconception is focusing only on whether a submission can be filed, while overlooking classification assessment, document consistency, product claims, post-market responsibilities, and target-country localization requirements. The earlier a gap assessment is conducted, the lower the risk of deficiency responses and rework.
AIMEILI Perspective
AIMEILI recommends that companies assess this question at project initiation rather than handling it immediately before submission. A more reliable approach is to complete product classification, documentation gap assessment, target-country prioritization, local responsible entity, and post-market maintenance arrangements, then develop an executable registration plan.
Continue Reading
- Previous: Can China's medical device classification results be used directly for overseas registration?
- Next: If the technical file is incomplete, can the registration be submitted first?
Recommended Reading
- What should be considered when selling a medical device software app on EU online platforms?
- When must a medical device change be submitted as a change notification?
- How should performance evaluation documents be prepared for overseas IVD product registration?
- How can medical device cybersecurity documents be prepared in advance?
- What does clinical evaluation documentation usually focus on?
- What should companies prepare before TGA medical device registration in Australia?
Content Review and Applicability Boundaries
Content author: AIMEILI Regulatory Editorial Team. Professional review: AIMEILI Medical Device International Registration Project Team. Source principles: prioritize official regulatory authorities, international organizations, standards organizations, and public regulatory materials; industry media and project experience are used only as supporting judgment. Applicability boundaries: This article is for preliminary understanding, document preparation, and project planning. It does not replace the formal requirements of target-country regulatory authorities, testing conclusions, or legal advice.
Related: Return to FAQ Center | News | Contact AIMEILI
Need a registration pathway assessment?
Send product type, intended use, target countries and existing certificates. AIMEILI can help evaluate registration pathway, documentation gaps and compliance risks.
Contact AIMEILI